What the Pill Looks Like. How it Works. Slows carbohydrate absorption. Reduces amount of sugar made by the liver. Increases release of insulin

Similar documents
Objectives. How Medicine Works to Control Blood Sugar Levels. What Happens When We Eat? What is diabetes? High Blood Glucose (Hyperglycemia)

TABLE 1A: Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations

TABLE 1A : Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations

Table 1. Antihyperglycemic agents for use in type 2 diabetes

Oral and Injectable Non-insulin Antihyperglycemic Agents

DIABETES (1 of 5) Generic. Generic $0 $5 $5-10 $0 $0 $0. Generic $0 $5 $5-10. Generic. Generic $0 $5 $5-10 $0 $0 $0. Generic $0 $5 $5-10 $0 $0 $0

Very Practical Tips for Managing Type 2 Diabetes

DIABETES. overview of pharmacologic agents used in the management of. Overview 4/3/2014 OBJECTIVES. Injectable Agents

Diabetes Medication Updates Erica Bukovich, PharmD, BC-ADM, CDE September 20, 2018

3. Cardiovascular Disease?

RPCC Pharmacy Forum. The Type 2 Diabetes Issue. Type 2 Diabetes: The Basics

Pharmacologic Agents for Treatment of Type 2 Diabetes

Images have been removed from the PowerPoint slides in this handout due to copyright restrictions. Insulins. Rapid Short Intermediate Long Mix

Objectives. Recognize all available medical treatment options for diabetes. Individualize treatment and glycemic target based on patient factors

Type 2 Diabetes: Where Do We Start with Treatment? DIABETES EDUCATION. Diabetes Mellitus: Complications and Co-Morbid Conditions

FARXIGA (dapagliflozin) Jardiance (empagliflozin) tablets. Synjardy (empagliflozin and metformin hydrochloride) tablets. GLUCOPHAGE* (metformin)

How to Fight Diabetes and Win. Diabetes. Medications

1/15/2018. Disclosures. Current Diabetes Medications. Objectives NON-INSULIN AGENTS. Diabetes Med Classes. Mealtime

Pharmacology Updates. Quang T Nguyen, FACP, FACE, FTOS 11/18/17

Physician Drug Reference Chart for Diabetes Antidiabetic Medications

I. General Considerations

Diabetes Treatment Guidelines

What s New in Diabetes Medications. Jena Torpin, PharmD

Diabetes Medications: Oral Anti-Hyperglycemic Medications

Diabetes Management: A diagnostic perspective

How can we improve outcomes in Type 2 diabetes?

Clinical Cases in Diabetes Management. Joseph Cook D.O.

4/9/2018 HOW TO REGULATE DIABETES MEDICATIONS. By Sarah Froemsdorf MSN, RNC, CDE, FNP DISCLOSURES NONE. Diagnosis

Update on Therapies for Type 2 Diabetes: Angela D. Mazza, DO July 31, 2015

Clinical Pharmacotherapeutic Applications of the American Diabetes Association Standards of Care 2018

Antidiabetic Agents CHAPTER BIGUANIDES

Improving Patient Outcomes with Individualized Therapy in the Management of Type 2 Diabetes

Collaborative Practice Agreement

Society for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery

2018 Diabetes Summit Managing Diabetes: An Art and a Science

Jonathan Stoehr, MD PhD Endocrinology, Diabetes, Metabolism and Nutrition Virginia Mason Medical Center Seattle, WA 2012 Virginia Mason Medical

Healthy You: A Guide to Diabetes Self-Care SURVIVAL SKILLS

How they work and when to take them. Diabetes Medications

Management of Type 2 Diabetes Mellitus. Heather Corn, MD, MS Endocrinology, Diabetes, and Metabolism

Diabetes Mellitus II CPG

What s New in Type 2 Diabetes? 2018 Diabetes Updates

Clinical Guidelines. Management of adult patients with diabetes undergoing endoscopic procedures

Oral Medication for the Management of Diabetes Mechanism of. Duration of Daily Dosing Action

Clinical Practice Guidelines

STEP THERAPY CRITERIA

Information for Patients

Managing Complex Diabetes Cases: Medication Update. Celia Levesque MSN, RN, CNS-BC, CDE, BC-ADM

Medications for Diabetes

Staying Healthy With Diabetes

Welcome to the PHASE Learning Community! October 31, 2018

Initiating Injectable Therapy in Type 2 Diabetes

What s New in Type 2 Diabetes? 2018 Diabetes Updates

The Death of Sulfonylureas? A Review of New Diabetes Medications

Pharmacology. Kacy Aderhold, MSN, APRN-CNS, CMSRN

Oral and Injectable Medication Options for Diabetes Treatment

continuing education for pharmacists

Diabetes 2016: Strategies for achieving optimal diabetes control

INSIGHTS PRACTICE INSULIN, PRIOR AUTHORIZATION, AND UTILIZATION MANAGEMENT DECEMBER 2017 DEVELOPED BY THE AMERICAN PHARMACISTS ASSOCIATION

Non-Insulin Diabetes Medications Summary

What s New in Diabetes Treatment. Disclosures

Diabetes Oral Agents Pharmacology. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

Antihyperglycemic Agents in Diabetes. Jamie Messenger, PharmD, CPP Department of Family Medicine East Carolina University August 18, 2014

Diabetes Basics. Type 1 diabetes The body cannot make insulin Requires insulin injection Is not treated with oral diabetes medicines (pills)

Search strategies key terms

Type 2 Diabetes Mellitus: Update on Pharmacotherapy 04/04/18

New Therapies for Diabetes

Let s not sugarcoat it! Update on Pharmacologic Management of Type II DM

CADTH THERAPEUTIC REVIEW New Drugs for Type 2 Diabetes: Second-Line Therapy Science Report

Advanced Practice Education Associates. Endocrine

Injectable Therapies in Diabetes

DIABETES. Mary Bruskewitz APNP, MS, BC-ADM Clinical Nurse Specialist Diabetes. November 2013

Type 2 Diabetes Mellitus hypoglycaemic agents

Treatment Options for Diabetes: An Update

TREATMENTS FOR TYPE 2 DIABETES. Susan Henry Diabetes Specialist Nurse

Caring for Your Diabetes:

Navigating the New Options for the Management of Type 2 Diabetes

DIABETES INDICATIONS FOR INSULIN

Drug Therapy in Diabetes HEATHER TINGLE UK COLLEGE OF PHARMACY, PY4

Drug Class Review Newer Diabetes Medications and Combinations

Newer Therapies for Type 2 Diabetes

In-Hospital Management of Diabetes. Dr Benjamin Schiff Assistant Professor McGill University

The Management of Diabetes in Primary Care Kelly Krawtz, PharmD, BCPS, BCACP

Drug Class Review Monograph GPI Class 27 Anti-diabetics

Side Effects of: GLP-1 agonists DPP-4 inhibitors SGLT-2 inhibitors. Bryce Fukunaga PharmD April 25, 2018

Making Sense of New DM Therapies and Technologies

Diabetes Update Bryan Heart Conference September 5, 2015 Shannon Wakeley, MD. Disclosures. Objectives 9/1/2015

New Therapies for Diabetes Management: Hope or Headache?

Fasted and Consented but Blood Glucose 18mmol/L or How to Manage Diabetes in the Peri-Operative Period

Comparison of GLP-1 Agonists

New Antidiabetic Medications

Update on Diabetic Medications UMA SUNDARAM, M.D. DIABETES & ENDOCRINE ASSOCIATES APRIL 07, 2018

TYP 2 DIABETES. Marc Donath

Diabetes Management in New Brunswick Nursing Homes

Remote attendees, please mute your phones as a courtesy thank you!

Medical care of diabetes - what s new?

Diabetes Update 10/12/2017. Section #1 OBJECTIVE. Lab features to consider:

Ministry of Health. BC Chronic Disease and Selected Procedure Case Definitions. Chronic Disease Information Working Group. Date Created: June 29, 2015

DM Fundamentals Class 4 Meds for Type 2

MANAGING DIABETES IN 2016 WHAT TO ADD, WHEN AND WHY?

MANAGING DIABETES IN 2017 WHAT TO ADD, WHEN AND WHY? December 8, 2017 Maria Wolfs MD MHSc FRCPC

Transcription:

Diabetes s Oral s - Pills These are some of the pills that are currently available in Canada to treat diabetes. Each medication has benefits and side effects you should be aware of. Your diabetes team will work with you to decide which one(s) will work best for you. Alpha-Glucosidase Inhibitors Acarbose (Glucobay) 50-100 mg Taken with each meal May cause gas and bloating A1C by 0.6% Cost: $$ Slows carbohydrate absorption Must treat low blood sugar with Dex4, milk, or honey Di-Peptidyl Peptidase-4 (DPP-4) Inhibitors A1C by 0.7% Cost: $$$ - Sitagliptin (Januvia) Saxagliptin (Onglyza) Linagliptin (Trajenta) Reduces sugar made by the liver Januvia: 25-100 mg Onglyza: 2.5-5 mg Trajenta: 5 mg May cause stomach discomfort and diarrhea Doses should be lowered or use Trajenta if poor kidney function Available as a combination pill with Metformin Sulfonylureas A1C by 0.8% Cost: $ (except Amaryl) Gliclazide (Diamicron) Diamicron MR (Modified Release) Glimepiride (Amaryl) Glyburide (Diabeta) Diamicron: 80-160 mg Twice a day Diamicron MR: 30-120 mg Amaryl: 1-8 mg Diabeta: 2.5-20 mg with food May cause weight gain May cause low (Highest risk with Diabeta, Lowest risk with Diamicron) Rash may occur if allergic to sulfa drugs

Meglitinides A1C by 0.7% Cost: $ Repaglinide (GlucoNorm) 0.5 mg 1.0 mg 2.0 mg 0.5-4 mg Taken with each meal May cause weight gain May cause low blood MUST be taken with food Biguanides A1C by 1.0-1.5 % Cost: $ to $$ (except Glumetza) Glucophage (Metformin) Metformin Extended Release (Glumetza) Enhances body's use of Metformin: 250-2000 mg Taken with food Glumetza: 1000-2000 mg Take with largest meal May cause diarrhea, nausea and bloating May cause B12 deficiency low Targets fasting blood Reduces sugar made by the liver Should not be taken if impaired kidney or liver function Available in combination with DPP- 4s or SGLT-2 Thiazolidinediones A1C by 0.8 % Cost: $$ Pioglitazone (Actos) Rosiglitazone (Avandia) Enhances body's use of Actos: 15-45 mg Avandia: 2-8 mg May cause weight gain May cause fluid retention Should not be taken if you have a heart condition Can not be taken if you use Targets fasting blood low

How it Works Sodium Glucose Co- Transporter 2 (SGLT-2) Inhibitors A1C by 0.7-1.0 % Cost: $$$ Canagliflozin (Invokana) Dapagliflozin (Forxiga) Empagliflozin (Jardiance) the sugar removed from the body in the urine Invokana 100 mg 300 mg Forxiga 5 mg 10 mg Jardiance 10 mg 25 mg Invokana: 100-300 mg Forxiga: 5-10mg Jardiance: 10-25mg May cause weight loss May cause UTI/yeast infection, low blood pressure, dehydration low Targets both fasting and after meal blood Weight Loss Agent A1C by 0.5% Cost: $$$$ Some Orlistat (Xenical) Inhibits fat absorption 120 mg Taken with meals (Skip dose if not eating a meal or if meal does not contain fat) May cause significant weight loss May cause diarrhea and other GI side effects low

Injectable s These are some of the injectable medications that are currently available in Canada to treat diabetes. Each medication has benefits and side effects you should be aware of. Most of these medications will lead to some weight loss and some have heart-protective benefits if you have a history of heart disease. Your diabetes team will work with you to decide which one will work best for you. What the Pen Glucagon-Like Protein 1 (GLP-1) Receptor Agonist A1C by 0.8-1.0% Cost: $$$$ Some Exenatide (Byetta) Exenatide XR (Bydureon) Liraglutide (Victoza or Saxenda) Lixisenatide (Adlyxine) Semaglutide (Ozempic) Stimulates release of after meals Slows digestion of carbohydrate Byetta: 5-10 mcg Twice daily Bydureon: 2mg Victoza: 0.6-1.8 mg (For Diabetes) Saxenda: 0.6-3.0 mg (For Weight Loss) Adlyxine: 10-20 mcg May cause significant weight loss May cause nausea, diarrhea, and other GI side effects Targets both fasting and after meal Dulaglutide (Trulicity) Reduces appetite Ozempic: 0.25-1.0mh Trulicity: 0.75-1.5 mg

Insulin Over time the pancreas may lose its ability to produce and regular injections will often be needed to achieve target blood sugar levels. Rapid and short acting s are taken with meals, intermediate or long acting s are taken once or twice daily. Your diabetes team will work with you to decide which one will work best for you. Type Brand Name Delivery Methods Onset Ultra Rapid-Acting Rapid-Acting Short-Acting Intermediate-Acting (cloudy) Long-Acting (except Toujeo/Tresiba) Fiasp ( aspart) Humalog ( lispro) Humalog U200 (concentrated lispro) NovoRapid ( aspart) Apidra ( glulisine) Humulin-R Novolin Toronto (Regular) Humulin N Novolin NPH Levemir ( detemir) Lantus ( glargine) Basaglar ( glargine) Toujeo (concentrated glargine) Tresiba (Degludec) U200 is only available as a pre-filled pen Toujeo and Tresiba are only available as a prefilled pen Peak Action Duration 2.5 minutes 1-2 hours 3-5 hours 10-15 minutes 1-2 hours 3-5 hours 30 minutes 2-3 hours 6.5 hours 1-3 hours 5-8 hours Up to 18 hours 90 minutes 6 hours 30-90 minutes Up to 24 hours 24-36 hours >42 hours Premixed s are available (Humulin 30/70, Novolin ge 30/70, 40/60, 50/50, NovoMix30, Humalog Mix 25 or Mix 50) which is a mixture of rapid or short acting with intermediate. These are typically used twice daily with the two largest meals of the day. The onset, peak action and duration will vary depending on the type of premixed. All pre-mixed is covered by except NovoMix 30. All pens contain 300u per pen except for Toujeo (450u per pen) and Tresiba U200 (600u per pen). The cost of depends on the dose you need.